Overview
Erythrocyte galactose epimerase deficiency, also known as red blood cell UDP-galactose-4-epimerase deficiency or peripheral epimerase deficiency, is a rare inherited metabolic condition that affects how the body processes the sugar galactose. Galactose is found mainly in milk and dairy products. In this condition, the enzyme called UDP-galactose-4-epimerase (GALE) does not work properly in red blood cells (and sometimes in white blood cells). This enzyme is needed to convert one form of galactose into another so the body can use or dispose of it properly. The peripheral (erythrocyte-only) form is generally considered the mildest type of galactose epimerase deficiency. Many people with this form have no symptoms at all and are discovered only through newborn screening, which may show elevated galactose levels in the blood. Because the enzyme deficiency is limited to blood cells and does not significantly affect the liver, brain, or other organs, most individuals remain healthy throughout life. However, it is important to distinguish this mild peripheral form from the more severe generalized or intermediate forms of epimerase deficiency, which can cause serious problems including liver disease, developmental delays, and cataracts. Proper diagnostic workup is essential to confirm which form a person has. In most cases of the erythrocyte-limited form, no treatment is needed, though some doctors may recommend monitoring galactose intake as a precaution. Regular follow-up with a metabolic specialist is advised, especially in infancy, to ensure the condition remains benign.
Also known as:
Key symptoms:
Elevated galactose levels found on newborn screeningUsually no noticeable symptomsMildly abnormal blood test results for galactose metabolismIn rare cases, mild jaundice in the newborn periodNo liver or brain problems in the peripheral form
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
1 availableNormocarb HF
Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances
Clinical Trials
View all trials with filters →No actively recruiting trials found for Erythrocyte galactose epimerase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Erythrocyte galactose epimerase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Erythrocyte galactose epimerase deficiency.
Community
No community posts yet. Be the first to share your experience with Erythrocyte galactose epimerase deficiency.
Start the conversation →Latest news about Erythrocyte galactose epimerase deficiency
No recent news articles for Erythrocyte galactose epimerase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has testing confirmed that my child has the mild peripheral form and not the more severe generalized form of epimerase deficiency?,Does my child need any dietary restrictions, and if so, for how long?,How often should we follow up with a metabolic specialist?,Should other family members be tested for carrier status?,Are there any long-term health risks I should watch for?,Will this condition affect my child's growth, development, or learning?,Should we get genetic counseling before planning future pregnancies?
Common questions about Erythrocyte galactose epimerase deficiency
What is Erythrocyte galactose epimerase deficiency?
Erythrocyte galactose epimerase deficiency, also known as red blood cell UDP-galactose-4-epimerase deficiency or peripheral epimerase deficiency, is a rare inherited metabolic condition that affects how the body processes the sugar galactose. Galactose is found mainly in milk and dairy products. In this condition, the enzyme called UDP-galactose-4-epimerase (GALE) does not work properly in red blood cells (and sometimes in white blood cells). This enzyme is needed to convert one form of galactose into another so the body can use or dispose of it properly. The peripheral (erythrocyte-only) for
How is Erythrocyte galactose epimerase deficiency inherited?
Erythrocyte galactose epimerase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Erythrocyte galactose epimerase deficiency typically begin?
Typical onset of Erythrocyte galactose epimerase deficiency is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for Erythrocyte galactose epimerase deficiency?
1 patient support program are currently tracked on UniteRare for Erythrocyte galactose epimerase deficiency. See the treatments and support programs sections for copay assistance, eligibility, and contact details.